Lung Cancer Trial, Recruiting NCT07591389 Sponsor: University of North Dakota Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT07591389
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman who is a mother of at least one child aged 4 years old or younger.
  • You own a smartphone.
  • The child you bring to the appointment is your biological or adoptive child.

Who may not be able to join:

  • You have had your home or environment tested for radon in the past 2 years.
  • The child you bring to the appointment is older than 4 years of age.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 701-777-2786

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of North Dakota
Registry
ClinicalTrials.gov
Start date
10 April 2026
Est. completion
1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

T1 (baseline: pre-exposure survey, distribution of free radon test kit); T2 (post-exposure survey at 2 months); T3 (end of kit tracking at 4 months)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov